Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer
نویسندگان
چکیده
منابع مشابه
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.
Although selective metabolic and receptor-based molecular agents will surely be included in the future of prostate cancer diagnosis and therapy, currently available inorganic compounds-such as 18F-NaF for the diagnosis of bony disease and 223RaCl2 for the therapy of bone metastases-were recently shown to be superior to standard 99mTc-phosphonates for diagnosis and 153Sm-ethylenediaminetetrameth...
متن کاملDevelopmental trends in targeted radionuclide therapy of neuroendocrine tumors
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms including carcinoids, pancreatic neuroendocrine tumors, pituitary tumors, medullary thyroid carcinoma and phaeochromocytomas. The symptoms and the outcome of NETs differ considerably between patients depending on several factors. By labelling tracers with a radioisotope, the tracer acts as a ...
متن کاملTargeted Multimodal Liposomes for Imaging and Radionuclide Therapy
GERBEN A. KONING*, WILLEM MULDER, GUSTAV J. STRIJKERS, KLAAS NICOLAY, SANDER ZIELHUIS, FRANK NIJSEN, MARJAN M. FRETZ, GERT STORM and GERARD C. KRIJGER Department of Radiation, Radioisotopes and Reactors, Delft University of Technology, Mekelweg 15, 2629-JB, Delft, The Netherlands, Department of Biomedical NMR, Eindhoven University of Technology, The Netherlands, Department of Nuclear Medicine, ...
متن کاملTargeted Radionuclide Therapy
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the possibility of assessing the uptake by the...
متن کاملTargeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
Aggressive variant prostate cancers (AVPC) are a clinically defined group of tumors of heterogeneous morphologies, characterized by poor patient survival and for which limited diagnostic and treatment options are currently available. We show that the cell surface 78-kDa glucose-regulated protein (GRP78), a receptor that binds to phage-display-selected ligands, such as the SNTRVAP motif, is a ca...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nuclear Medicine
سال: 2016
ISSN: 0161-5505,2159-662X
DOI: 10.2967/jnumed.116.175497